An experimental coronavirus treatment pill is making headlines on Friday (October 1). The oral drug, called molnupiravir, is being developed by Merck & Co Inc. and Ridgeback Biotherapeutics LP, and reduced hospitalization and death by around 50% according to clinical trial results, via Reuters. Click inside to read more… The… Read entire story.
Source: Just Jared